Drug Profile
Research programme: apoptosis inducers - Idun Pharmaceuticals
Latest Information Update: 27 Nov 2007
Price :
$50
*
At a glance
- Originator University of Texas Southwestern Medical Center
- Class
- Mechanism of Action Apoptosis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Cardiovascular disorders; Stroke
Most Recent Events
- 06 Nov 2002 No development reported - Preclinical for Cancer in USA (unspecified route)
- 06 Nov 2002 No development reported - Preclinical for Cardiovascular disorders in USA (unspecified route)
- 06 Nov 2002 No development reported - Preclinical for Stroke in USA (unspecified route)